Survival time of advanced gastric cancer patients treated with integrated traditional Chinese and Western medicine therapy

Journal of Chinese Integrative Medicine

Volumn 8, Issue 2, 2010, Pages 116-120

  Cao, Ni Da ^a   Zhao, Ai Guang ^a   Yang, Jin Kun ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Controlled clinical trial; Gastric cancer; Integrated traditional Chinese and Western medicine therapy; Quality of life; Survival time

Indexed keywords

ADULT; ADVANCED CANCER; APPETITE; ARTICLE; BODY WEIGHT; CANCER GROWTH; CANCER PAIN; CANCER SURVIVAL; CHINESE MEDICINE; CONTROLLED STUDY; FATIGUE; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MEDICINE; NAUSEA AND VOMITING; QUALITY OF LIFE; SLEEP; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME; WESTERN MEDICINE;

DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; NEOPLASM STAGING; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77749320947     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20100204     Document Type: Article

References (17)

1. Van Cutsem E. The treatment of advanced gastric cancer: new findings on the activity of the taxanes. Oncologist. 2004; 9(Suppl 2): 9-15.
2. Qin SK, Gong XL. Chemotherapy of advanced gastric carcinoma: current status and prospects. Lin Chuang Zhong Liu Xue Za Zhi. 2006; 11(9): 641-652. Chinese.
3. Sun DZ, Xu L, Jiang LD, Wei PK. Evaluation of the quality of clinical literatures of traditional Chinese medicine for gastric carcinoma. Zhongguo Lin Chuang Yi Xue. 2003; 10(6): 833-835. Chinese with abstract in English.
4. Chinese Anticancer Association. New criteria for diagnosis and treatment of common malignant tumors, 2nd ed. Beijing: Peking Union Medical College Press. 1999. Chinese.
5. Shimada K, Ajani JA. Adjuvant therapy for gastric carcinoma patients in the past 15 years: a review of Western and oriental trials. Cancer. 1999; 86(9): 1657-1668.
6. Shen ZY, Wang WJ. Reference criteria for differentiation of deficiency syndromes in traditional Chinese medicine. Zhong Xi Yi Jie He Za Zhi. 1986; 5(10): 698. Chinese.
7. Ministry of Health of the People's Republic of China. Guidelines for clinical research on Chinese new herbal medicines (trial implementation). Beijing: Medical Science and Technology Publishing House of China. 2002. Chinese.
8. Jin ML. Chemotherapy of advanced gastric cancer. Zhongguo Shi Yong Wai Ke Za Zhi. 2000; 20(10): 628-630. Chinese.
9. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H, Takcuchi M. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trials): a phase III trial. Lancet Oncol. 2008; 9(3): 215-221.
10. Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J, Norman AR; Upper Gastrointestinal Clinical Studies Group of the National Cancel Research Institute of the United Kingdom. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med. 2008; 358(1): 36-46.
11. Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi E, Risse ML. Ajani JA; V325 Study Group. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first line therapy for advanced gastric cancer; a report of the V325 study group. J Clin Oncol. 2006; 24(31): 4991-4997.
12. U.S. Department of Health and Human Service, U. S. Food and Drug Administration. Guidance for industry: clinical trial endpoints for the approval of cancer drugs and biologics. 2007.
13. Yang JK, Zheng J. Academic experience of Qiu Jiaxin in treating malignant tumor of digestive track. Shanghai Zhong Yi Yao Za Zhi. 1995; (2): 8-10. Chinese.
14. Yang JK, Zhao AG, Zhao HL. Experimental study of Weichang' an in inducing apoptosis in human gastric cancer. Zhong Yi Yao Xue Kan. 2003; 21(6): 908-909. Chinese.
15. Zhao HL, Zhao AG, You SF, Gu Y, Tang LD, Yang JK. Growth-inhibiting and anti-metastasis effects of Weichang'an Decoction on orthotopic transplant nude mouse model of human gastric cancer. J Chin Integr Med. 2005; 3(5): 378-381. Chinese with abstract in English.
16. Zheng J, Gu Y, Zhou H, Zhu YJ, Han YY, Shen KP. Effects of traditional Chinese herbal drugs for strengthening spleen on the living period, metastasis and recurrence of the advanced gastric cancer. Liaoning Zhong Yi Za Zhi. 2003; 30(8): 683-685. Chinese with abstract in English.
17. Yang JK, Shen KP, Zhao HL. Tube infusion of traditional Chinese herbal medicine in treatment of 56 cases of obstructive alimentary malignant tumor. Shanghai Zhong Yi Yao Za Zhi. 2001; (6): 15-16. Chinese.